MTHFR and chronic kidney disease: In our study, we subsequently confirmed that the IMOD in CKD patients on conservative therapy represents a useful tool for the prevention of CVDs, inducing a significant reduction of serum Hcy influenced by the methylenetetrahydrofolate reductase (MTHFR) genotype [23].